Insider · CIK 0002027850
Timothy J. Lorber
Files at SHPH (Shuttle Pharmaceuticals Holdings, Inc.). First filing -, latest -.
In brief
Timothy J. Lorber files SEC Form 4 as CFO at SHPH (Shuttle Pharmaceuticals Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Timothy J. Lorber has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | AGrant or award Restricted Stock Unitderivative | +29,240 | $0.00 | $0 | 29,240 | Aug 12, 2025 |
| Aug 8, 2025 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | AGrant or award Restricted Stock Unitderivative | +24,854 | $0.00 | $0 | 24,854 | Aug 12, 2025 |
Questions about Timothy J. Lorber
Answered from the filings on this page, as of the latest one.
Is Timothy J. Lorber buying or selling?
Timothy J. Lorber has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Timothy J. Lorber's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Timothy J. Lorber has 0.
Where does Timothy J. Lorber file Form 4?
Timothy J. Lorber has filed Form 4 at SHPH (Shuttle Pharmaceuticals Holdings, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.